Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial is a research paper published in European Heart Journal Open (2023). On theSindex it has a DataRank of 0.452. It has been cited 12 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.0674
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
Maryland Stem Cell Research Fund
Grant: #2017-MSCRFCL-3955
National Heart, Lung, and Blood Institute
Grant: R01HL118491
National Heart, Lung, and Blood Institute
Grant: R01 HL139060-01A1
National Heart, Lung, and Blood Institute
Grant: R42HL131226-01
National Heart, Lung, and Blood Institute
Grant: R01 HL107110
National Heart, Lung, and Blood Institute
Grant: 1R01HL134558-01
National Heart, Lung, and Blood Institute
Grant: 4R01HL084275-10
National Heart, Lung, and Blood Institute
Grant: 5R01HL116899-04
National Heart, Lung, and Blood Institute
Grant: HHSN268201600012I
National Cancer Institute
Grant: 5R01CA136387-07
National Heart, Lung, and Blood Institute
Grant: R01HL145644
Marcus Foundation
National Institute on Aging, the MSCRF, and Alzheimer’s Association
Children’s Heart Foundation
National Institutes of Health
Soffer Family Foundation
Moseley Foundation
NIH
Starr Foundation
FWCI
1.11
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals